Scientific Updates Get updates: Email RSS
PPMI Diffusion Tensor Imaging data presented at AD/PD 2013 in Florence, Italy
Yu Zhang from the University of California at San Francisco presented data on the visualization and quantification of the striato-pallidonigral fibers in PD using DTI at the 11th International Conference on Alzheimer's and Parkinson's Diseases in Florence, Italy.
Continue reading...PPMI Scientific Leadership to Present on PPMI at 2013 SNMMI Annual Meeting
John Seibyl, member of the PPMI Steering Committee, will present on the initial quantitative 123-I Ioflupane SPECT one year disease progression data in the PPMI PD cohort.at The Society of Nuclear Medicine and Molecular Imaging’s 2013 Annual Meeting
Continue reading...MDS 2013 Poster: “Relationship between Serum Urate and Clinical Features in Early Parkinson’s Disease: PPMI Baseline Data”
A poster submitted by Radu Constantinescu, MD of the Center for Human Experimental Therapeutics (CHET) at the University of Rochester Medical Center has been accepted for the poster session at the Movement Disorder Society’s International Congress this June in Sydney, Australia.
Continue reading...Feasibility and Safety of Lumbar Punctures in PPMI presented at AAN
Boston University PPMI Site Principal Investigator, Samuel Frank, presented data on the feasibility and safety of lumbar punctures in PPMI at the American Academy of Neurology’s 75th annual meeting on March 19th, 2013 in San Diego, CA.
Continue reading...PPMI Bioanalytics Core PI presented at the International Conference on Alpha-Synuclein in Dubai, UAE
Dr. Trojanowski, PI of the PPMI Bioanalytics Core presented on early Synuclein analyses that have been done in PPMI during the Biomarkers session at the International Conference on Alpha-Syunclein in Parkinson’s Disease on March 3, 2013 at 9:45 AM in Dubai. For more information on this presentation, please visit our new Presentations section of the website.
Continue reading...Biospecimen Review Committee Evaluating Requests for PPMI Samples
PPMI’s Biospecimen Review Committee (BRC) convenes every other month to review requests to use available specimens being housed at Corriell, which serves as the PPMI biorepository. To date, 23 requests have been made for use of the biospecimens. Two of those requests have been accepted and fulfilled.
Continue reading...PPMI launches new prodromal cohort
PPMI has launched a new study arm to enroll and follow a prodromal PD cohort with the goal of providing researchers with the opportunity to examine biomarker progression prior to the onset of motor symptoms. This new cohort seeks to enroll subjects without Parkinson’s disease who have at least one of the following characteristics: hyposmia, REM sleep behavior disorder, LRRK2 genetic mutation.
Continue reading...PPMI Recruitment Finishes, Complete Cohort Baseline Analysis Coming Soon
PPMI has now finished recruiting the 400 de novo PD and 200 control subjects the study originally set out to identify. This is an important milestone for the study and for those wishing to take advantage of its growing dataset. Already, more than 54,000 downloads have been made from scientists in 37 countries across the globe. In the coming months, the PPMI Steering Committee plans to present at various meetings and publish a paper that will reference the baseline data as a description of the 600+ participants enrolled in PPMI.
Continue reading...Select Preliminary Baseline Data for 90% of Cohort Recruited is Presented at AAN
PPMI senior leadership presented PPMI data collected so far at the American Academy of Neurology’s 75th annual meeting. The poster used baseline data to give a preliminary sense of the characteristics of the PPMI cohort. The poster also highlights CSF acquisition success rates in PPMI and data from baseline DaTSCANs.
Continue reading...PPMI Ancillary Studies in Full Swing
An update on the integration of SWEDD's, TAP-PD, fMRI, tracking MCI and dementia, and inclusion of exercise assessment as ancillary studies in PPMI
Continue reading...
